Pages that link to "Q73523907"
Jump to navigation
Jump to search
The following pages link to Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis (Q73523907):
Displaying 50 items.
- Viral hepatitis and hepatocellular carcinoma (Q21245597) (← links)
- Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C (Q24201588) (← links)
- Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients (Q24653596) (← links)
- Effect of adjuvant interferon therapy on hepatitis B virus-related hepatocellular carcinoma: a systematic review (Q26747293) (← links)
- Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia-Pacific region (Q27026753) (← links)
- Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action (Q27693179) (← links)
- Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function (Q28066295) (← links)
- Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more? (Q28201474) (← links)
- Management of hepatocellular carcinoma (Q29616230) (← links)
- Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver (Q29616866) (← links)
- Management strategies for hepatocellular carcinoma: old certainties and new realities. (Q30252143) (← links)
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (Q30479629) (← links)
- Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma (Q33391833) (← links)
- Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis (Q33421303) (← links)
- Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients. (Q33807745) (← links)
- Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease (Q34098540) (← links)
- Effect of sustained virological response on long-term clinical outcome in 113 patients with compensated hepatitis C-related cirrhosis treated by interferon alpha and ribavirin (Q34233163) (← links)
- Long-Term Effects of Antiviral Therapy in Patients with Chronic Hepatitis C (Q34415157) (← links)
- Effects and outcomes of interferon treatment in Japanese hepatitis C patients (Q34443253) (← links)
- Treatment of chronic hepatitis C with PEGylated interferon and ribavirin (Q34515630) (← links)
- Peginterferon and ribavirin treatment for hepatitis C virus infection (Q34521371) (← links)
- Long-term interferon therapy after radiofrequency ablation is effective in treating patients with HCV-associated hepatocellular carcinoma (Q34553534) (← links)
- Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis (Q34572884) (← links)
- Management of chronic hepatitis B and C virus infections (Q34584886) (← links)
- Prevention of liver cancer (Q34921207) (← links)
- Treatment of chronic hepatitis C: a systematic review (Q34984085) (← links)
- A meta-analysis and systematic review: adjuvant interferon therapy for patients with viral hepatitis-related hepatocellular carcinoma. (Q34995738) (← links)
- Polyethylene glycol-interferon: current status in hepatitis C virus therapy (Q35020845) (← links)
- Hepatocellular carcinoma: present status and future prospects (Q35068060) (← links)
- Radical causes of cancer. (Q35097371) (← links)
- Interferon for preventing and treating hepatocellular carcinoma associated with the hepatitis B and C viruses (Q35170763) (← links)
- Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. (Q35179465) (← links)
- Providing treatment for hepatitis C in an Australian district centre (Q35518843) (← links)
- Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival (Q35552046) (← links)
- Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations. (Q35627943) (← links)
- Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study (Q35747990) (← links)
- Impact of hepatitis C virus eradication on hepatocellular carcinogenesis (Q35985401) (← links)
- Surveillance for gastrointestinal malignancies (Q36214550) (← links)
- Impact of antiviral therapy on hepatocellular carcinoma and mortality in patients with chronic hepatitis C: systematic review and meta-analysis. (Q36334385) (← links)
- Hepatocellular carcinoma: therapy and prevention (Q36377949) (← links)
- The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area (Q36473813) (← links)
- Predictive impact of polymorphism of PNPLA3 on HCC development after interferon therapy in Japanese patients with chronic hepatitis C. (Q36927621) (← links)
- Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. (Q37174403) (← links)
- Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea (Q37205937) (← links)
- Managing pediatric hepatitis C: current and emerging treatment options (Q37316248) (← links)
- Hepatocellular carcinoma: A global view. (Q37589349) (← links)
- Epidemiology and management of hepatocellular carcinoma. (Q37629940) (← links)
- Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros (Q37765049) (← links)
- Effects of a Sustained Virologic Response on Outcomes of Patients With Chronic Hepatitis C (Q37893724) (← links)
- Antiviral therapy for prevention of hepatocellular carcinoma in chronic hepatitis C: systematic review and meta-analysis of randomised controlled trials (Q38054307) (← links)